CoChat
Sign Up
Cited by 680

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Mast cells and inflammation

Theoharides, Theoharis C., Alysandratos, Konstantinos-Dionysios, Angelidou, Asimenia, Delivanis, Danae-Anastasia, Sismanopoulos, Nikolaos, Zhang, Bodi, Asadi, Shahrzad, Vasiadi, Magdalini, Weng, Zuyi, Miniati, Alexandra, Kalogeromitros, Dimitrios·2012·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DOI 10.1016/j.bbadis.2010.12.014PMC PMC3318920
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2010.12.014

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 304

  1. Rodewald, 1996, Identification of a committed precursor for the mast cell lineage, Science, 271, 818, 10.1126/science.271.5250.818 · DOI · Paper page
  2. Chen, 2005, Identification of mast cell progenitors in adult mice, Proc. Natl Acad. Sci. USA, 102, 11408, 10.1073/pnas.0504197102 · DOI · Paper page
  3. Kitamura, 2005, Mast cell-committed progenitors, Proc. Natl Acad. Sci. USA, 102, 11129, 10.1073/pnas.0505073102 · DOI
  4. Hundley, 2004, Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells, Blood, 104, 2410, 10.1182/blood-2004-02-0631 · DOI
  5. Blank, 2004, The ins and outs of IgE-dependent mast-cell exocytosis, Trends Immunol., 25, 266, 10.1016/j.it.2004.03.005 · DOI
  6. Siraganian, 2003, Mast cell signal transduction from the high-affinity IgE receptor, Curr. Opin. Immunol., 15, 639, 10.1016/j.coi.2003.09.010 · DOI
  7. Kraft, 2007, New developments in FcepsilonRI regulation, function and inhibition, Nat. Rev. Immunol., 7, 365, 10.1038/nri2072 · DOI
  8. Aloe, 1977, Mast cells increase in tissues of neonatal rats injected with the nerve growth factor, Brain Res., 133, 358, 10.1016/0006-8993(77)90772-7 · DOI
  9. Tam, 1997, Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells, Blood, 90, 1807, 10.1182/blood.V90.5.1807 · DOI
  10. Metz, 2004, Neurotrophin-3 regulates mast cell functions in neonatal mouse skin, Exp. Dermatol., 13, 273, 10.1111/j.0906-6705.2004.00115.x · DOI
  11. Lorentz, 2007, Neurotrophin-3, but not nerve growth factor, promotes survival of human intestinal mast cells, Neurogastroenterol. Motil., 19, 301, 10.1111/j.1365-2982.2007.00899.x · DOI
  12. Tal, 1997, Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw, Neurosci. Lett., 221, 129, 10.1016/S0304-3940(96)13318-8 · DOI
  13. Conti, 1997, Impact of Rantes and MCP-1 chemokines on in vivo basophilic mast cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase, Blood, 89, 4120, 10.1182/blood.V89.11.4120 · DOI
  14. Cima, 2010, Sensory neuropeptides are potent chemoattractants for human basophils in vitro, Regul. Pept., 160, 42, 10.1016/j.regpep.2009.12.013 · DOI
  15. Bischoff, 2007, Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data, Nat. Rev. Immunol., 7, 93, 10.1038/nri2018 · DOI
  16. Redegeld, 2005, Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions?, Trends Immunol., 24, 181, 10.1016/S1471-4906(03)00059-0 · DOI
  17. Redegeld, 2002, Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses, Nat. Med., 8, 694, 10.1038/nm722 · DOI
  18. Theoharides, 1996, Mast cell: a neuroimmunoendocrine master player, Int. J. Tissue React., 18, 1
  19. Theoharides, 2004, Critical role of mast cells in inflammatory diseases and the effect of acute stress, J. Neuroimmunol., 146, 1, 10.1016/j.jneuroim.2003.10.041 · DOI
  20. Goetzl, 1990, Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities, Clin. Exp. Allergy, 20, 3, 10.1111/j.1365-2222.1990.tb02469.x · DOI
  21. Foreman, 1987, Peptides and neurogenic inflammation, Brain Res. Bull., 43, 386
  22. Janiszewski, 1994, Picomolar doses of substance P trigger electrical responses in mast cells without degranulation, Am. J. Physiol., 267, C138, 10.1152/ajpcell.1994.267.1.C138 · DOI
  23. Matsuda, 1989, Substance P induces granulocyte infiltration through degranulation of mast cells, J. Immunol., 142, 927, 10.4049/jimmunol.142.3.927 · DOI
  24. Zhang, 2000, Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis, Nat. Immunol., 1, 392, 10.1038/80826 · DOI
  25. Carraway, 1982, Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels, J. Physiol., 323, 403, 10.1113/jphysiol.1982.sp014080 · DOI
  26. Bienenstock, 1987, The role of mast cells in inflammatory processes: evidence for nerve mast cell interactions, Int. Arch. Allergy Appl. Immunol., 82, 238, 10.1159/000234197 · DOI · Paper page
  27. De Simone, 1990, Nerve growth factor released into the bloodstream following intraspecific fighting induces mast cell degranulation in adult male mice, Brain Behav. Immun., 4, 74, 10.1016/0889-1591(90)90008-E · DOI
  28. Seebeck, 1998, Pituitary adenylate cyclase activating polypeptide induces degranulation of rat peritoneal mast cells via high-affinity PACAP receptor-independent activation of G proteins, Ann. NY Acad. Sci., 865, 141, 10.1111/j.1749-6632.1998.tb11172.x · DOI
  29. Odum, 1998, Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells, Inflamm. Res., 47, 488, 10.1007/s000110050363 · DOI
  30. Goetzl, 1985, Neuropeptide regulation of the expression of immediate hypersensitivity, J. Immunol., 135, 802s, 10.4049/jimmunol.135.2.802 · DOI
  31. Fewtrell, 1982, The effects of substance P on histamine and 5-hydroxytryptamine release in the rat, J. Physiol., 330, 393, 10.1113/jphysiol.1982.sp014347 · DOI
  32. Toyoda, 2000, Immunolocalization of substance P in human skin mast cells, Arch. Dermatol. Res., 292, 418, 10.1007/s004030000149 · DOI
  33. Xiang, 2000, IgE receptor-mediated release of nerve growth factor by mast cells, Clin. Exp. Allergy, 30, 1379, 10.1046/j.1365-2222.2000.00906.x · DOI
  34. Allakhverdi, 2007, Thymic stromal lymphopoietin is released by human epithelial cell in response to microbes, trauma, or inflammation and potently activates mast cells, J. Exp. Med., 19, 253, 10.1084/jem.20062211 · DOI
  35. Bashyam, 2007, TSLP-tickled mast cells, J. Exp. Med., 204, 209, 10.1084/jem.2042iti3 · DOI
  36. Dvorak, 1997, New aspects of mast cell biology, Int. Arch. Allergy Immunol., 114, 1, 10.1159/000237635 · DOI
  37. Serafin, 1987, Mediators of immediate hypersensitivity reactions, N. Engl. J. Med., 317, 30, 10.1056/NEJM198707023170106 · DOI · Paper page
  38. Schwartz, 1987, Mediators of human mast cells and human mast cell subsets, Ann. Allergy, 58, 226
  39. Galli, 1993, New concepts about the mast cell, N. Engl. J. Med., 328, 257, 10.1056/NEJM199301283280408 · DOI
  40. Holgate, 2000, The role of mast cells and basophils in inflammation, Clin. Exp. Allergy, 30, 28, 10.1046/j.1365-2222.2000.00093.x · DOI
  41. Galli, 2005, Mast cells as “tunable” effector and immunoregulatory cells: recent advances, Annu. Rev. Immunol., 23, 749, 10.1146/annurev.immunol.21.120601.141025 · DOI · Paper page
  42. Grutzkau, 1998, Synthesis, storage and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206, Mol. Biol. Cell, 9, 875, 10.1091/mbc.9.4.875 · DOI
  43. Cao, 2005, Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor, J. Immunol., 174, 7665, 10.4049/jimmunol.174.12.7665 · DOI · Paper page
  44. Chalmers, 1996, Corticotropin-releasing factor receptors: from molecular biology to drug design, Trends Pharmacol. Sci., 17, 166, 10.1016/0165-6147(96)81594-X · DOI
  45. Chen, 1993, Expression cloning of a human corticotropin-releasing factor receptor, Proc. Natl Acad. Sci. USA, 90, 8967, 10.1073/pnas.90.19.8967 · DOI
  46. Lovenberg, 1995, Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain, Proc. Natl Acad. Sci. USA, 92, 836, 10.1073/pnas.92.3.836 · DOI
  47. Lovenberg, 1995, CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues, Endocrinology, 136, 4139, 10.1210/endo.136.9.7544278 · DOI
  48. Vaughan, 1995, Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor, Nature, 378, 287, 10.1038/378287a0 · DOI
  49. Million, 2002, Human urocortin II, a new CRF related peptide, displays selective CRF2-mediated action on gastric transit in rats, Am. J. Physiol. Gastrointest. Liver Physiol., 282, G34, 10.1152/ajpgi.00283.2001 · DOI
  50. Lewis, 2001, Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF 2 receptor, Proc. Natl Acad. Sci. USA, 98, 7570, 10.1073/pnas.121165198 · DOI · Paper page
  51. Karalis, 1997, CRH and the immune system, J. Neuroimmunol., 72, 131, 10.1016/S0165-5728(96)00178-6 · DOI · Paper page
  52. Kempuraj, 2004, Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells, Endocrinology, 145, 43, 10.1210/en.2003-0805 · DOI
  53. Theoharides, 2004, Mast cells as targets of corticotropin-releasing factor and related peptides, Trends Pharmacol. Sci., 25, 563, 10.1016/j.tips.2004.09.007 · DOI
  54. Paus, 2006, Neuroimmunoendocrine circuitry of the ‘brain–skin connection’, Trends Immunol., 27, 32, 10.1016/j.it.2005.10.002 · DOI
  55. Ito, 2010, Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme, J. Invest. Dermatol., 130, 995, 10.1038/jid.2009.387 · DOI
  56. Bradding, 1995, Heterogeneity of human mast cells based on cytokine content, J. Immunol., 155, 297, 10.4049/jimmunol.155.1.297 · DOI
  57. Levi-Schaffer, 1986, Co-culture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells, Proc. Natl Acad. Sci. USA, 83, 6485, 10.1073/pnas.83.17.6485 · DOI
  58. Bischoff, 1999, IL-4 enhances proliferation and mediator release in mature human mast cells, Proc. Natl Acad. Sci. USA, 96, 8080, 10.1073/pnas.96.14.8080 · DOI
  59. Bischoff, 2001, Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells, Int. Arch. Allergy Immunol., 124, 151, 10.1159/000053695 · DOI
  60. Ochi, 2000, IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production, Proc. Natl Acad. Sci. USA, 97, 10509, 10.1073/pnas.180318697 · DOI
  61. Galli, 2005, Mast cells in the development of adaptive immune responses, Nat. Immunol., 6, 135, 10.1038/ni1158 · DOI
  62. Maurer, 2004, Mast cells promote homeostasis by limiting endothelin-1-induced toxicity, Nature, 432, 512, 10.1038/nature03085 · DOI · Paper page
  63. Abraham, 2010, Mast cell-orchestrated immunity to pathogens, Nat. Rev. Immunol., 10, 440, 10.1038/nri2782 · DOI · Paper page
  64. Rottem, 2005, Mast cells and autoimmunity, Autoimmun. Rev., 4, 21, 10.1016/j.autrev.2004.05.001 · DOI
  65. O'Connor, 2010, The dual nature of T(H)17 cells: shifting the focus to function, Nat. Immunol., 11, 471, 10.1038/ni.1882 · DOI
  66. Piconese, 2009, Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation, Blood, 114, 2639, 10.1182/blood-2009-05-220004 · DOI
  67. Nakae, 2007, Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice, Blood, 109, 3640, 10.1182/blood-2006-09-046128 · DOI
  68. Yadav, 2008, Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity, Ann. N.Y. Acad. Sci., 1144, 83, 10.1196/annals.1418.020 · DOI
  69. Woolhiser, 2004, Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a, Clin. Immunol., 110, 172, 10.1016/j.clim.2003.11.007 · DOI
  70. Kraneveld, 2005, Elicitation of allergic asthma by immunoglobulin free light chains, Proc. Natl Acad. Sci. USA, 102, 1578, 10.1073/pnas.0406808102 · DOI
  71. Chen, 2007, Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability, Eur. J. Immunol., 37, 434, 10.1002/eji.200636379 · DOI
  72. Bachelet, 2007, Mast cells as effector cells: a co-stimulating question, Trends Immunol., 28, 360, 10.1016/j.it.2007.06.007 · DOI
  73. Mekori, 1999, Mast cell–T cell interactions, J. Allergy Clin. Immunol., 104, 517, 10.1016/S0091-6749(99)70316-7 · DOI
  74. Nakae, 2006, Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF, J. Immunol., 176, 2238, 10.4049/jimmunol.176.4.2238 · DOI
  75. Nakae, 2005, Mast cells enhance T cell activation: importance of mast cell-derived TNF, Proc. Natl Acad. Sci. USA, 102, 6467, 10.1073/pnas.0501912102 · DOI
  76. Theoharides, 2007, Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis, Adv. Exp. Med. Biol., 601, 423, 10.1007/978-0-387-72005-0_45 · DOI
  77. Kempuraj, 2008, Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells, Br. J. Pharmacol., 155, 1076, 10.1038/bjp.2008.356 · DOI
  78. Shefler, 2010, T cell-induced mast cell activation: a role for microparticles released from activated T cells, J. Immunol., 185, 4206, 10.4049/jimmunol.1000409 · DOI
  79. Kunder, 2009, Mast cell-derived particles deliver peripheral signals to remote lymph nodes, J. Exp. Med., 206, 2455, 10.1084/jem.20090805 · DOI
  80. Gong, 2010, The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II, BMC Immunol., 11, 34, 10.1186/1471-2172-11-34 · DOI
  81. Novak, 2004, Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis, Curr. Allergy Asthma Rep., 4, 263, 10.1007/s11882-004-0069-2 · DOI
  82. Poncet, 1999, MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation, J. Leukoc. Biol., 66, 105, 10.1002/jlb.66.1.105 · DOI
  83. Stelekati, 2009, Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions, Immunity, 31, 665, 10.1016/j.immuni.2009.08.022 · DOI
  84. Yoshimoto, 2009, Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide–MHC class II complexes to CD4+ T cells, Nat. Immunol., 10, 706, 10.1038/ni.1737 · DOI
  85. Sokol, 2009, Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response, Nat. Immunol., 10, 713, 10.1038/ni.1738 · DOI
  86. Sokol, 2010, Role of basophils in the initiation of Th2 responses, Curr. Opin. Immunol., 22, 73, 10.1016/j.coi.2010.01.012 · DOI
  87. Yoshimoto, 2010, Basophils as T(h)2-inducing antigen-presenting cells, Int. Immunol., 22, 543, 10.1093/intimm/dxq052 · DOI
  88. Tang, 2010, The T helper type 2 response to cysteine proteases requires dendritic cell–basophil cooperation via ROS-mediated signaling, Nat. Immunol., 11, 608, 10.1038/ni.1883 · DOI
  89. Charles, 2010, Basophils and the T helper 2 environment can promote the development of lupus nephritis, Nat. Med., 16, 701, 10.1038/nm.2159 · DOI
  90. Galli, 2008, Immunomodulatory mast cells: negative, as well as positive, regulators of immunity, Nat. Rev. Immunol., 8, 478, 10.1038/nri2327 · DOI
  91. Frossi, 2010, Exploring a regulatory role for mast cells: ‘MCregs’?, Trends Immunol., 31, 97, 10.1016/j.it.2009.12.007 · DOI
  92. Theoharides, 1981, Mast cells and precursor protein molecules, Perspect. Biol. Med., 24, 499, 10.1353/pbm.1981.0019 · DOI
  93. Cochrane, 1993, Stimulated rat mast cells generate histamine-releasing peptide from albumin, Peptides, 14, 117, 10.1016/0196-9781(93)90018-C · DOI
  94. Carraway, 1986, Pepsin treatment of mammalian plasma generates immunoreactive and biologically active neurotensin-related peptides in micromolar concentrations, Endocrinology, 119, 1519, 10.1210/endo-119-4-1519 · DOI
  95. Cochrane, 1991, Rapid degradation of neutotensin by stimulated rat mast cells, Peptides, 12, 1187, 10.1016/0196-9781(91)90193-S · DOI
  96. Piliponsky, 2008, Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis, Nat. Med., 14, 392, 10.1038/nm1738 · DOI
  97. Hultner, 2005, Mast cells and endothelin-1: a life-saving biological liaison?, Trends Immunol., 26, 235, 10.1016/j.it.2005.03.007 · DOI
  98. Damerau, 1975, Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom, Naunyn-Schmiedeberg's Arch. Pharmacol., 287, 141, 10.1007/BF00510446 · DOI
  99. Liu, 1991, The amino acid sequence and properties of an edema-inducing Lys-49 phospholipase A2 homolog from the venom of Trimeresurus mucrosquamatus, Biochim. Biophys. Acta, 1077, 362, 10.1016/0167-4838(91)90552-B · DOI
  100. Metz, 2006, Mast cells can enhance resistance to snake and honeybee venoms, Science, 313, 526, 10.1126/science.1128877 · DOI · Paper page
  101. Woolley, 2003, The mast cell in inflammatory arthritis, N. Engl. J. Med., 348, 1709, 10.1056/NEJMcibr023206 · DOI
  102. Harvima, 1993, Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis, Psychother. Psychosom., 60, 168, 10.1159/000288690 · DOI
  103. Özdamar, 1996, Mast cells in psoriasis, Dermatology, 192, 190, 10.1159/000246359 · DOI
  104. Theoharides, 1990, Mast cells: the immune gate to the brain, Life Sci., 46, 607, 10.1016/0024-3205(90)90129-F · DOI
  105. Jayapal, 2006, Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses, BMC Genomics, 7, 210, 10.1186/1471-2164-7-210 · DOI
  106. Carraway, 1989, Structures of histamine-releasing peptides formed by the action of acid proteases on mammalian albumin(s), J. Immunol., 143, 1680, 10.4049/jimmunol.143.5.1680 · DOI
  107. Schmidlin, 2001, Protease-activated receptors: how proteases signal to cells, Curr. Opin. Pharmacol., 1, 575, 10.1016/S1471-4892(01)00099-6 · DOI
  108. Molino, 1997, Interactions of mast cell tryptase with thrombin receptors and PAR-2, J. Biol. Chem., 272, 4043, 10.1074/jbc.272.7.4043 · DOI
  109. Theoharides, 2007, Differential release of mast cell mediators and the pathogenesis of inflammation, Immunol. Rev., 217, 65, 10.1111/j.1600-065X.2007.00519.x · DOI
  110. Theoharides, 1978, Secretion in mast cells induced by calcium entrapped within phospholipid vesicles, Science, 201, 1143, 10.1126/science.684435 · DOI
  111. Van Loveren, 1984, Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses, Eur. J. Immunol., 14, 40, 10.1002/eji.1830140108 · DOI
  112. Dimitriadou, 1991, Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells, Neuroscience, 44, 97, 10.1016/0306-4522(91)90253-K · DOI
  113. Letourneau, 1996, Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis, Br. J. Urol., 77, 41, 10.1046/j.1464-410X.1996.08178.x · DOI
  114. Dvorak, 1992, Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo, Int. Arch. Allergy Immunol., 99, 74, 10.1159/000236338 · DOI
  115. Theoharides, 1982, Differential release of serotonin and histamine from mast cells, Nature, 297, 229, 10.1038/297229a0 · DOI
  116. Tamir, 1982, Serotonin storage pools in basophil leukemia and mast cells: characterization of two types of serotonin binding protein and radioautographic analysis of the intracellular distribution of [3H] serotonin, J. Cell Biol., 93, 638, 10.1083/jcb.93.3.638 · DOI
  117. Spencer, 2006, Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion, Proc. Natl Acad. Sci. USA, 103, 3333, 10.1073/pnas.0508946103 · DOI
  118. Kandere-Grzybowska, 2003, IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells, J. Immunol., 171, 4830, 10.4049/jimmunol.171.9.4830 · DOI
  119. Benyon, 1989, Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli, Br. J. Pharmacol., 97, 898, 10.1111/j.1476-5381.1989.tb12030.x · DOI
  120. Levi-Schaffer, 1989, Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides, Int. Arch. Allergy Appl. Immunol., 90, 352, 10.1159/000235052 · DOI
  121. van Haaster, 1995, Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells; roles of cytosolic calcium and protein tyrosine kinases, Biochim. Biophys. Acta, 1265, 79, 10.1016/0167-4889(94)00210-6 · DOI
  122. Leal-Berumen, 1994, IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide, J. Immunol., 152, 5468, 10.4049/jimmunol.152.11.5468 · DOI
  123. Marquardt, 1996, The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production, J. Immunol., 156, 1942, 10.4049/jimmunol.156.5.1942 · DOI
  124. Gagari, 1997, Differential release of mast cell interleukin-6 via c-kit, Blood, 89, 2654, 10.1182/blood.V89.8.2654 · DOI
  125. Cao, 2006, Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway, Mol. Pharmacol., 69, 998, 10.1124/mol.105.019539 · DOI
  126. Abdel-Majid, 2004, Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells, J. Immunol., 172, 1227, 10.4049/jimmunol.172.2.1227 · DOI
  127. Nakayama, 2006, Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells, J. Leukoc. Biol., 79, 95, 10.1189/jlb.0405226 · DOI
  128. Kay, 2006, Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation, Br. J. Pharmacol., 147, 707, 10.1038/sj.bjp.0706664 · DOI
  129. Lin, 2000, Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha, J. Immunol., 165, 211, 10.4049/jimmunol.165.1.211 · DOI
  130. Fischer, 2006, Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion, J. Clin. Invest., 116, 2748, 10.1172/JCI24274 · DOI
  131. Ho, 2007, IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals, J. Leukoc. Biol., 82, 1481, 10.1189/jlb.0407200 · DOI
  132. Aderem, 2000, Toll-like receptors in the induction of the innate immune response, Nature, 406, 782, 10.1038/35021228 · DOI
  133. Okayama, 2005, Mast cell-derived cytokine expression induced via Fc receptors and Toll-like receptors, Chem. Immunol. Allergy, 87, 101, 10.1159/000087574 · DOI
  134. Gondokaryono, 2007, The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4, J. Leukoc. Biol., 82, 657, 10.1189/jlb.1206730 · DOI
  135. McCurdy, 2003, Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells, J. Immunol., 170, 1625, 10.4049/jimmunol.170.4.1625 · DOI
  136. Masuda, 2002, Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways, J. Immunol., 169, 3801, 10.4049/jimmunol.169.7.3801 · DOI
  137. Varadaradjalou, 2003, Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells, Eur. J. Immunol., 33, 899, 10.1002/eji.200323830 · DOI
  138. Qiao, 2006, FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells, Blood, 107, 610, 10.1182/blood-2005-06-2271 · DOI
  139. Supajatura, 2002, Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity, J. Clin. Invest., 109, 1351, 10.1172/JCI0214704 · DOI
  140. Matsushima, 2004, TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells, J. Immunol., 173, 531, 10.4049/jimmunol.173.1.531 · DOI
  141. Ikeda, 2003, Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences, J. Immunol., 171, 4860, 10.4049/jimmunol.171.9.4860 · DOI
  142. Kulka, 2004, Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3, J. Allergy Clin. Immunol., 114, 174, 10.1016/j.jaci.2004.03.049 · DOI
  143. Hepp, 2005, Phosphorylation of SNAP-23 regulates exocytosis from mast cells, J. Biol. Chem., 280, 6610, 10.1074/jbc.M412126200 · DOI
  144. Nishida, 2005, Fc{epsilon}RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane, J. Cell Biol., 170, 115, 10.1083/jcb.200501111 · DOI
  145. Lessmann, 2006, A redundant role for PKC-epsilon in mast cell signaling and effector function, Int. Immunol., 18, 767, 10.1093/intimm/dxl012 · DOI
  146. Rivera, 2006, Molecular regulation of mast cell activation, J. Allergy Clin. Immunol., 117, 1214, 10.1016/j.jaci.2006.04.015 · DOI
  147. Furumoto, 2006, Cutting edge: lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival, J. Immunol., 176, 5167, 10.4049/jimmunol.176.9.5167 · DOI
  148. Stempelj, 2005, Signaling pathway in nerve growth factor induced histamine release from rat mast cells, Inflamm. Res., 54, 344, 10.1007/s00011-005-1364-7 · DOI
  149. Kandere-Grzybowska, 2006, Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin, Br. J. Pharmacol., 148, 208, 10.1038/sj.bjp.0706695 · DOI
  150. Forssell, 2005, Interleukin-2-inducible T cell kinase regulates mast cell degranulation and acute allergic responses, Am. J. Respir. Cell Mol. Biol., 32, 511, 10.1165/rcmb.2004-0348OC · DOI
  151. Seow, 2002, Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro, Eur. J. Pharmacol., 443, 189, 10.1016/S0014-2999(02)01534-0 · DOI
  152. Kepley, 2005, Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels, Int. Arch. Allergy Immunol., 138, 29, 10.1159/000087355 · DOI
  153. Oka, 2004, IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells, Am. J. Physiol. Cell Physiol., 286, C256, 10.1152/ajpcell.00197.2003 · DOI
  154. Gonzalez-Espinosa, 2003, Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells, J. Exp. Med., 197, 1453, 10.1084/jem.20021806 · DOI
  155. Odom, 2004, Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase, J. Exp. Med., 199, 1491, 10.1084/jem.20040382 · DOI
  156. Gomez, 2005, Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells1, J. Immunol., 175, 7602, 10.4049/jimmunol.175.11.7602 · DOI
  157. Rivera, 2006, Adaptors discriminate mast-cell cytokine production from eicosanoid production and degranulation, Trends Immunol., 27, 251, 10.1016/j.it.2006.04.001 · DOI
  158. Klemm, 2006, The Bcl10–Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation, J. Exp. Med., 203, 337, 10.1084/jem.20051982 · DOI
  159. Bachelet, 2005, The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells, J. Immunol., 175, 7989, 10.4049/jimmunol.175.12.7989 · DOI
  160. Cherwinski, 2005, The CD200 receptor is a novel and potent regulator of murine and human mast cell function, J. Immunol., 174, 1348, 10.4049/jimmunol.174.3.1348 · DOI
  161. Karra, 2009, Are we ready to downregulate mast cells?, Curr. Opin. Immunol., 21, 708, 10.1016/j.coi.2009.09.010 · DOI
  162. Andrasfalvy, 2005, The beta subunit of the type I Fcepsilon receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells, J. Immunol., 175, 2801, 10.4049/jimmunol.175.5.2801 · DOI
  163. Theoharides, 2000, Chondroitin sulfate inhibits connective tissue mast cells, Br. J. Pharmacol., 131, 1039, 10.1038/sj.bjp.0703672 · DOI
  164. Davis, 2004, Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells, J. Immunol., 173, 6914, 10.4049/jimmunol.173.11.6914 · DOI
  165. Conti, 2003, IL-10, an inflammatory/inhibitory cytokine, but not always, Immunol. Lett., 86, 123, 10.1016/S0165-2478(03)00002-6 · DOI
  166. He, 2004, Inhibition of histamine release from human mast cells by natural chymase inhibitors, Acta Pharmacol. Sin., 25, 822
  167. Tagen, 2009, Mitochondrial uncoupling protein 2 (UCP2) inhibits mast cell activation and reduces histamine content, J. Immunol., 183, 6313, 10.4049/jimmunol.0803422 · DOI
  168. Zhang, 2010, TNF secretion from human mast cells is regulated by mitochondrial dynamics and mitochondrial uncoupling protein 2 (UCP2), J. Immunol., 184, 11, 10.4049/jimmunol.184.Supp.135.11 · DOI
  169. Zhang, 2011, Human mast cell degranulation and granule-stored TNF secretion require mitochondrial translocation to exocytosis sites—relevance to atopic dermatitis, J Allergy Clin Immunol., 127, 1522, 10.1016/j.jaci.2011.02.005 · DOI
  170. Middleton, 2000, The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer, Pharmacol. Rev., 52, 673, 10.1016/S0031-6997(24)01472-8 · DOI · Paper page
  171. Kempuraj, 2005, Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells, Br. J. Pharmacol., 145, 934, 10.1038/sj.bjp.0706246 · DOI
  172. Fiorani, 2010, Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid, J. Nutr. Biochem., 21, 397, 10.1016/j.jnutbio.2009.01.014 · DOI
  173. Katsarou-Katsari, 1999, Effect of stress and other psychological factors on the pathophysiology and treatment of dermatoses, Int. J. Immunopathol. Pharmacol., 12, 7
  174. Church, 1999, Human skin mast cells: in vitro and in vivo studies, Ann. Allergy Asthma Immunol., 83, 471, 10.1016/S1081-1206(10)62853-0 · DOI
  175. Alysandratos, 2010, Increased affected skin gene expression and serum levels of thymic stromal lymphopoietin in atopic dermatitis, Ann. Allergy Asthma Immunol., 105, 403, 10.1016/j.anai.2010.09.017 · DOI
  176. Soumelis, 2002, Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP, Nat. Immunol., 3, 673, 10.1038/ni805 · DOI
  177. Lee, 2010, Increased serum thymic stromal lymphopoietin in children with atopic dermatitis, Pediatr. Allergy Immunol., 21, e457, 10.1111/j.1399-3038.2009.00919.x · DOI
  178. Kimata, 2003, Enhancement of allergic skin wheal responses and in vitro allergen-specific IgE production by computer-induced stress in patients with atopic dermatitis, Brain Behav. Immun., 17, 134, 10.1016/S0889-1591(03)00025-4 · DOI
  179. Kimata, 2003, Enhancement of allergic skin wheal responses in patients with atopic eczema/dermatitis syndrome by playing video games or by a frequently ringing mobile phone, Eur. J. Clin. Investig., 33, 513, 10.1046/j.1365-2362.2003.01177.x · DOI
  180. Slominski, 2000, Neuroendocrinology of the skin, Endocr. Rev., 21, 457
  181. Slominski, 2000, Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress, Physiol. Rev., 80, 979, 10.1152/physrev.2000.80.3.979 · DOI · Paper page
  182. Slominski, 1995, Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin, FEBS Lett., 374, 113, 10.1016/0014-5793(95)01090-2 · DOI
  183. Skofitsch, 1985, Corticotropin-releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other neuropeptides, Peptides, 6, 307, 10.1016/0196-9781(85)90057-9 · DOI
  184. Merchenthaler, 1983, Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat spinal cord, Brain Res., 275, 373, 10.1016/0006-8993(83)91001-6 · DOI
  185. Kubler, 1994, Intra and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone, Clin. Investig., 72, 331, 10.1007/BF00252822 · DOI
  186. Theoharides, 1998, Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects, Endocrinology, 139, 403, 10.1210/endo.139.1.5660 · DOI
  187. Crompton, 2003, Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways, J. Clin. Endocrinol. Metab., 88, 5427, 10.1210/jc.2003-030377 · DOI
  188. Clifton, 2002, Microvascular effects of CRH in human skin vary in relation to gender, J. Clin. Endocrinol. Metab., 87, 267, 10.1210/jcem.87.1.8149 · DOI
  189. Papadopoulou, 2005, Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria, J. Invest. Dermatol., 125, 952, 10.1111/j.0022-202X.2005.23913.x · DOI
  190. Lytinas, 2003, Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists, Int. Arch. Allergy Immunol., 130, 224, 10.1159/000069516 · DOI
  191. Dhabhar, 1999, Enhancing versus suppressive effects of stress hormones on skin immune function, Proc. Natl Acad. Sci. USA, 96, 1059, 10.1073/pnas.96.3.1059 · DOI
  192. Kaneko, 2003, Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats, Exp. Dermatol., 12, 47, 10.1034/j.1600-0625.2003.120106.x · DOI
  193. Singh, 1999, Acute immobilization stress triggers skin mast cell degranulation via corticotropin-releasing hormone, neurotensin and substance P: a link to neurogenic skin disorders, Brain Behav. Immun., 13, 225, 10.1006/brbi.1998.0541 · DOI
  194. Singh, 1999, Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors, J. Pharmacol. Exp. Ther., 288, 1349, 10.1016/S0022-3565(24)38092-9 · DOI
  195. Katsarou-Katsari, 1999, Stress and inflammatory dermatoses, Int. J. Immunopathol. Pharmacol., 12, 7
  196. Fortune, 2005, Psychologic factors in psoriasis: consequences, mechanisms, and interventions, Dermatol. Clin., 23, 681, 10.1016/j.det.2005.05.022 · DOI
  197. Harvima, 1996, Association of psychic stress with clinical severity and symptoms of psoriatic patients, Acta Derm.-Venereol. (Stockh.), 76, 467, 10.2340/0001555576467471 · DOI
  198. Tagen, 2007, Skin corticotropin-releasing hormone receptor expression in psoriasis, J. Invest. Dermatol., 127, 1789, 10.1038/sj.jid.5700757 · DOI
  199. Harvima, 2008, Is there a role for mast cells in psoriasis?, Arch. Dermatol. Res., 300, 461, 10.1007/s00403-008-0874-x · DOI
  200. Saraceno, 2006, The role of neuropeptides in psoriasis, Br. J. Dermatol., 155, 876, 10.1111/j.1365-2133.2006.07518.x · DOI

200 of 304 shown

Cited by

Sorted by citations

See all 680

Metadata

Authors
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., & Kalogeromitros, D.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2012-01
Volume
1822
Issue
1
Pages
21-33
ISSN
0925-4439
DOI
10.1016/j.bbadis.2010.12.014
PMC
PMC3318920
Cited by
680
References
7
Language
en
Licence
Funders
US National Institutes of Health (NIH) (AR47652, NS71361, NS55681, NS66205)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mast cells and inflammation. https://app.cochat.ai/papers/10.1016/j.bbadis.2010.12.014
The paper
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., & Kalogeromitros, D. (2012). Mast cells and inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2010.12.014